High Flow Nasal Cannula Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

The high-flow nasal cannula market size is projected to reach US$ 18.5 billion by 2031 from US$ 7.2 billion in 2023. The market is expected to register a CAGR of 12.5% during 2023–2031. The growing incidence of astama and COPD across the globe, the rising geriatric population, and the growth of medical science in emerging nations are likely to remain key trends in the market.

High Flow Nasal Cannula Market Analysis

The number of cases of asthma and COPD has been growing all over the world at a substantial rate. In recent years, the number of smokers and the levels of air pollution in developed and developing countries have been increasing across the globe. Asthma is a medical condition where the airways swell and narrow and also produces mucus. This further leads to wheezing, coughing, and recurrent attacks of breathlessness, which differ in severity and frequency from person to person.  According to the World Health Organization estimates, there are approximately 235 million people suffering from asthma around the world. Moreover, the Centers for Disease Control and Prevention (CDC) reported, approximately19 million adults in the United States (18 years of age or above) are currently suffering from asthma, which accounts for almost 7.7% of the total adult population. Whereas about 6.2 million patients below 18 years of age have asthma, which accounts for 8.4% of the total children population.

High Flow Nasal Cannula Market Overview

The key factors that are driving the growth of the market are rising incidences if asthma and COPD across the globe and the rising geriatric population. However, the side effects associated with the use of high-flow nasal cannula is expected to hamper the growth of the market. The high-flow nasal cannula market is estimated to have a larger share in the United States. The growth of the high-flow nasal cannula market in the United States is expected to grow due to the rise in the cases of respiratory disorders, coupled with the presence of market players offering innovative solutions in the market.  Fisher & Paykel Healthcare Limited and ResMed are among the players holding a significant share of the global high-flow nasal cannula market. For instance, in March 2019, ResMed acquired HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

High Flow Nasal Cannula Market: Strategic Insights

High Flow Nasal Cannula Market

• 
  CAGR (2023 - 2031)

  12.5%
• Market Size 2023
  US$ 7.2 Billion
• Market Size 2031
  US$ 18.5 Billion

Market Dynamics

GROWTH DRIVERS

• Growing Applications of High Flow Nasal Cannula in Healthcare to Drive High Flow Nasal Cannula Market Growth

FUTURE TRENDS

• Growing Geriatric Population

OPPORTUNITIES

• Emerging Market of Asia Pacific

Key Players

• Fisher Paykel Healthcare Limited
• ResMed
• Great Group Medical Co Ltd
• Salter Labs
• TNI Medical Ag
• Mek Ics Co Ltd
• Flexicare Medical Limited
• Vapotherm
• Teleflex Incorporated
• Hamilton Medical

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Component

• Air Oxygen Blender
• Nasal Cannula
• Heated Inspiratory Circuit
• Active Humidifier

Application

• Bronchiectasis
• Acute Respiratory Failure
• Acute Heart Failure
• Chronic Obstructive Pulmonary Disease

End User

• Ambulatory Care Centers
• Hospital
• Long-Term Care Centers

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

High Flow Nasal Cannula Market Drivers and Opportunities

Increasing Risk of COPD in Geriatric Population to Favor Market

COPD and asthma are senescence condition which leads to gradual complications. Asthma in older adults is a critical condition that often goes unnoticed, as per the Asthma and Allergy Foundation of America (AAFA). According to the Office of Disease Prevention and Health Promotion (ODPHP), approximately 23 million people in the U.S. have some form of asthma, most of which include the older population. Older people with asthma often need high doses of medication in spite of mild asthma attacks. Hence, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age. However, it is more prevalent in the older population and can be fatal. The aging population is growing exponentially worldwide.

Penetration of Advanced Medical Service in Emerging Nation to Favor Market

The growing healthcare industry in developing countries in the Asia Pacific region is creating better opportunities for significant market players to expand their businesses. This is a major reason for the market growth in the forecast period. Most of the major players focus on emerging markets such as India, China, and others as they have a large number of patients suffering respiratory disorders and growing medical tourism in developing countries. Many of the emerging countries are preferred locations for medical tourism. According to the global burden of disease data, India has 18 % of the world’s population, but it has 32% of the global burden of respiratory diseases of the global nasal flow cannula market share.

High Flow Nasal Cannula Market Report Segmentation Analysis

Key segments that contributed to the derivation of the high-flow nasal cannula market analysis are products & services, applications, and end users.

• Based on Products & Services, the high-flow nasal cannula market is divided into services, consumables, and software. The services segment held a larger market share in 2023.
• The market is segmented by application into research & development activities, diagnostics, therapeutics, and others. The research & development activities segment held the largest share of the market in 2023.
• In terms of end users, the market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The academic & research institutes segment held a significant share of the market in 2023.

High Flow Nasal Cannula Market Share Analysis by Geography

The geographic scope of the high flow nasal cannula market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.  North America has largest market share of the high-flow nasal cannula market, by geography. Factors such as prevalence of respiratory disorders and the presence of promising government plans for the development of the care being provided to the patients for respiratory problems such as COPD and asthma. In the US, asthma and chronic obstructive pulmonary disease (COPD) are the substantial public health burdens. Governments are therefore taking initiative and creating patient-centric national guidelines for COPD that are accessible and easy for healthcare professionals to follow. For instance, with existing COPD guidelines, available from the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), create clinical practice guidelines that set reliable national standards for identifying people at risk for COPD as well as diagnosing and treating people with COPD across the care continuum. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

High Flow Nasal Cannula Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

High Flow Nasal Cannula Market News and Recent Developments

The high flow nasal cannula market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the high flow nasal cannula market are listed below:

• Masimo announced the U.S. introduction of softFlow, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients. (Source: Masimo, Press Release, April 2021)
• Fisher & Paykel Healthcare Corporation Limited announced that it has released the Airvo 3 high flow system. This device incorporates the company’s OptiO2™ closed-loop system for targeted oxygen delivery, which helps to ensure the patient is provided the right level of oxygen. Other new features include an integrated battery, a large touchscreen interface, expanded settings for pediatric and neonatal patients, and an increased maximum flow rate of 70 litres per minute compared to 60 litres per minute on the Airvo 2. (Source: Fisher & Paykel Healthcare Limited, Press Release, May 2022)

High Flow Nasal Cannula Market Report Coverage and Deliverables

The “High Flow Nasal Cannula Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• High Flow Nasal Cannula market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• High Flow Nasal Cannula market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• High Flow Nasal Cannula market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the High Flow Nasal Cannula market
• Detailed company profiles